Skip to content

A comparison of Quadratus Lumborum block and Epidural block for reducing post operative pain.

A comparative study of Quadratus Lumborum block vs Epidural block for post operative analgesia in patients with gynecological malignancies. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057563
Enrollment
52
Registered
2023-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C571- Malignant neoplasm of broad ligament Health Condition 2: C539- Malignant neoplasm of cervix uteri, unspecified Health Condition 3: C512- Malignant neoplasm of clitoris Health Condition 4: C549- Malignant neoplasm of corpus uteri, unspecified Health Condition 5: C530- Malignant neoplasm of endocervix Health Condition 6: C541- Malignant neoplasm of endometrium Health Condition 7: C531- Malignant neoplasm of exocervix Health Condition 8: C570- Malignant neoplasm of fallopi

Interventions

Intervention1: Quadratus Lumborum block: Bilateral US-guided transmuscular QLB will be administered at the level of L4. A 10 cm block needle will be inserted and 25 ml of Ropivacaine (0.2%) will be

Sponsors

AIIMS, New Delhi, 110029
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants selected will be adult patients aged 18–75 years of age with gynecological cancers and who are scheduled for cytoreductive/debulking surgery.

Exclusion criteria

Exclusion criteria: The following patients will be excluded from the study: Lack of mental ability to use a PCA pump, ASA PS grade iii and iv, obesity (BMI >30 kg/m2), any contraindication to an epidural catheter insertion (i.e. coagulopathy as defined by platelet count less than 90,000 and INR >1.5, local skin infection, etc.), patients already taking analgesics for pain, surgeries involving bowel resection, splenectomy or removal of any other organ except the uterus and adnexal masses.

Design outcomes

Primary

MeasureTime frame
The primary objective will be to compare between Quadratus lumborum & epidural groups, the amount (in mg) of postoperative morphine consumed at 24 hours.Timepoint: The primary objective will be to compare between Quadratus lumborum & epidural groups, the amount (in mg) of postoperative morphine consumed at 24 hours.

Secondary

MeasureTime frame
Consumption of morphine at 2, 6, 12 & 48h post operatively.Timepoint: 2 hours, 6 hours, 12 hours, 48 hours.;Numerical rating score for pain at 2, 6, 12 & 48h post operatively.Timepoint: 2 hours, 6 hours, 12 hours, 48 hours.;Incidence of complications i.e hypotension & motor blockade requiring alteration or pause in epidural administration.Timepoint: 48 hours;Time to first mobilization.Timepoint: 48 hours;Incidence of post operative nausea and/or vomiting requiring treatment.Timepoint: 48 hours;Length of hospital stay. Timepoint: Not applicable

Countries

India

Contacts

Public ContactDr Anvi Gupta

AIIMS, New Delhi, 110029

kelika.prakash@gmail.com9540947117

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026